4//SEC Filing
Lalwani Nikhil 4
Accession 0001822629-24-000006
CIK 0001023024other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 7:25 PM ET
Size
8.5 KB
Accession
0001822629-24-000006
Insider Transaction Report
Form 4
Lalwani Nikhil
DirectorPRESIDENT & CEO
Transactions
- Tax Payment
Common Stock
2024-03-07$66.71/sh−17,060$1,138,073→ 427,921 total - Sale
Common Stock
2024-03-06$65.52/sh−28,965$1,897,787→ 444,981 total - Sale
Common Stock
2024-03-08$67.13/sh−16,292$1,093,682→ 411,629 total
Footnotes (3)
- [F1]The shares were sold in multiple trades at prices ranging from $65.00 to $66.01. The price reported above reflects the weighted average sales price.
- [F2]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 33,352 shares of restricted stock, the grant of which was previously reported.
- [F3]The shares were sold in multiple trades at prices ranging from $66.42 to $67.74. The price reported above reflects the weighted average sales price.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001822629
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 7:25 PM ET
- Size
- 8.5 KB